ELVN Enliven Therapeutics, Inc. - Common Stock

NASDAQ · Pharmaceuticals · View on SEC EDGAR ↗
$58.97
Price · Aug 19, 2026
Fundamentals as of Aug 5, 2026

ELVN Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range

Price
$58.97
Market Cap
$3.51B
P/E (TTM)
-32.2
EPS (TTM)
$-1.83
Revenue (TTM)
Div Yield
ROE
-21.9%
Debt/Equity
52W Range
$15 – $62

ELVN Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view

10-Year Performance Revenue, net income, margins and EPS trends

Revenue & Net Income
EPS $-1.83
5-point trend, +22.8%
2021-12-31 2025-12-31
Free Cash Flow $-70M
6-point trend, -88.3%
2020-12-31 2025-12-31
Margins

Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?

Metric
5Y trend
ELVN
Peer Median
P/E (TTM)
5-point trend, -121.6%
-32.2
38.7
P/B
5-point trend, -27.6%
7.6
3.8
Price / FCF
5-point trend, -156.9%
-49.7

Profitability Gross, operating and net margins; ROE, ROA, ROIC

Metric
5Y trend
ELVN
Peer Median
ROA
5-point trend, +53.6%
-25.9%
-6.4%
ROE
5-point trend, +60.5%
-21.9%
-16.8%

Financial Health Debt, liquidity, solvency — balance sheet strength

Metric
5Y trend
ELVN
Peer Median
Current Ratio
5-point trend, +122.9%
28.7
12.8
Quick Ratio
5-point trend, +316.7%
27.9

Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR

Metric
5Y trend
ELVN
Peer Median

Per Share Metrics EPS, book value per share, cash flow per share, dividend per share

Metric
5Y trend
ELVN
Peer Median
EPS (Diluted)
5-point trend, +22.8%
$-1.83

Capital Efficiency Asset turnover, inventory turnover, receivables turnover

Metric
5Y trend
ELVN
Peer Median

ELVN Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside

BUY 18 analysts
  • Strong Buy 7 38.9%
  • Buy 10 55.6%
  • Hold 1 5.6%
  • Sell 0 0.0%
  • Strong Sell 0 0.0%

12-Month Price Target

9 analysts · 2026-08-17
Median target $70.00 +18.7%
Mean target $72.22 +22.5%

Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date

Avg Surprise
0.01%
Period EPS Actual EPS Est Surprise
June 30, 2026 $-0.49 $-0.41 -0.08%
March 31, 2026 $-0.38 $-0.47 0.09%
Dec. 31, 2025 $-0.48 $-0.39 -0.09%
Sept. 30, 2025 $-0.32 $-0.44 0.12%
June 30, 2025 $-0.49 $-0.54 0.05%
March 31, 2025 $-0.57 $-0.51 -0.06%

Peer comparison (GICS sub-industry) Key metrics vs sector peers

Ticker Market Cap P/E Rev YoY Net Margin ROE Gross Margin
ELVN $915M -8.4 -21.9%
AMRX 57.3 8.1% 2.4% -80.0% 36.9%
LGND $3.74B 30.8 60.4% 46.4% 13.5%
EWTX $2.64B -15.2 -30.2%
INDV 21.9 4.3% 17.0% -118.3% 80.2%
MANE 82.6%
GPCR $14.78B -86.9 -12.3%
OGN $1.87B 10.0 -2.9% 3.0% 25.2% 53.3%
MBX $1.42B -13.3 -29.6%
ALMS -3.4 -1011.8% -61.9%

Full Fundamentals All metrics by year — income statement, balance sheet, cash flow

Income Statement 13
Annual Income Statement data for ELVN
Metric Trend 2025202420232022202120202019
R&D Expense 7-point trend, +351.7% $86M $81M $65M $31M $38M $32M $19M
SG&A Expense 7-point trend, +561.9% $34M $24M $19M $8M $13M $10M $5M
Operating Expenses 7-point trend, +396.2% $120M $105M $84M $39M $51M $42M $24M
Operating Income 7-point trend, -396.2% $-120M $-105M $-84M $-39M $-51M $-42M $-24M
Other Non-op 7-point trend, -165.3% $-49.0K $-2.0K $-22.0K $0 $-175.0K $-145.0K $75.0K
Pretax Income 2-point trend, +103.1% · · · $2M $-51M · ·
Income Tax 4-point trend, +0.00 $0 $232.0K $0 $0 · · ·
Net Income 7-point trend, -341.9% $-104M $-89M $-72M $-38M $-51M $-41M $-23M
EPS (Basic) 5-point trend, +22.8% $-1.83 $-1.89 $-2.01 $-12.05 $-2.37 · ·
EPS (Diluted) 5-point trend, +22.8% $-1.83 $-1.89 $-2.01 $-12.05 $-2.37 · ·
Shares (Basic) 5-point trend, +161.6% 56,664,226 47,072,532 35,546,215 3,124,274 21,661,450 · ·
Shares (Diluted) 5-point trend, +161.6% 56,664,226 47,072,532 35,546,215 3,124,274 21,661,450 · ·
EBITDA 6-point trend, -186.2% $-119M $-104M $-83M $730.0K $-51M $-42M ·
Balance Sheet 22
Annual Balance Sheet data for ELVN
Metric Trend 2025202420232022202120202019
Cash & Equivalents 7-point trend, +1903.6% $99M $124M $100M $76M $48M $48M $5M
Short-term Investments 4-point trend, +363725000.00 $364M $189M $153M $0 · · ·
Prepaid Expense 7-point trend, +613.9% $12M $5M $3M $2M $2M $2M $2M
Current Assets 7-point trend, +1450.7% $475M $318M $266M $78M $93M $90M $31M
PP&E (Net) 7-point trend, -92.3% $34.0K $458.0K $742.0K $890.0K $250.0K $349.0K $442.0K
PP&E (Gross) 7-point trend, -44.6% $263.0K $1M $1M $1M $479.0K $479.0K $475.0K
Accum. Depreciation 7-point trend, +593.9% $229.0K $919.0K $671.0K $374.0K $229.0K $130.0K $33.0K
Other Non-current Assets 7-point trend, -70.6% $656.0K $7M $4M $0 $175.0K $88.0K $2M
Total Assets 7-point trend, +1330.0% $476M $326M $272M $83M $94M $91M $33M
Accounts Payable 7-point trend, +30.2% $2M $1M $532.0K $3M $2M $2M $2M
Accrued Liabilities 4-point trend, -33.8% · · · $2M $5M $4M $3M
Current Liabilities 7-point trend, +294.7% $17M $16M $26M $10M $7M $6M $4M
Capital Leases 3-point trend, -100.0% $0 · $0 · $406.0K · ·
Other Non-current Liabilities 4-point trend, -100.0% $0 $0 $67.0K $659.0K · · ·
Total Liabilities 7-point trend, +278.1% $17M $16M $26M $10M $8M $6M $4M
Common Stock 7-point trend, +5800.0% $59.0K $49.0K $41.0K $1.0K $27.0K $18.0K $1.0K
Paid-in Capital 7-point trend, +13632.5% $806M $553M $400M $6M $234M $181M $6M
Retained Earnings 7-point trend, -534.1% $-347M $-243M $-154M $-83M $-147M $-96M $-55M
AOCI 7-point trend, +943.8% $334.0K $55.0K $141.0K $0 $-16.0K $4.0K $32.0K
Stockholders' Equity 7-point trend, +1040.9% $460M $310M $246M $-77M $-43M $84M $-49M
Liabilities + Equity 7-point trend, +1330.0% $476M $326M $272M $83M $94M $91M $33M
Shares Outstanding 7-point trend, +8361.1% 59,440,045 48,936,459 41,292,027 3,570,019 26,287,264 17,548,263 702,510
Cash Flow 11
Annual Cash Flow data for ELVN
Metric Trend 2025202420232022202120202019
D&A 4-point trend, +50.0% $300.0K $300.0K $300.0K $200.0K · · ·
Stock-based Comp 7-point trend, +3684.1% $34M $20M $13M $3M $4M $2M $899.0K
Other Non-cash 3-point trend, +68.1% $-926.0K $-5M $-3M · · · ·
Operating Cash Flow 7-point trend, -221.3% $-70M $-73M $-61M $-32M $-47M $-37M $-22M
CapEx 7-point trend, +12.9% $158.0K $44.0K $149.0K $612.0K $12.0K $18.0K $140.0K
Investing Cash Flow 7-point trend, -622.5% $-174M $-36M $-148M $-612.0K $-2M $-17M $-24M
Stock Issued 3-point trend, +0.00 · $0 $161M $0 · · ·
Net Stock Activity 2-point trend, -100.0% · $0 $161M · · · ·
Financing Cash Flow 7-point trend, +402.2% $219M $133M $234M $-2M $49M $97M $44M
Taxes Paid 2-point trend, -100.0% $0 $209.0K · · · · ·
Free Cash Flow 6-point trend, -88.3% $-70M $-73M $-61M $-36M $-47M $-37M ·
Profitability 3
Annual Profitability data for ELVN
Metric Trend 2025202420232022202120202019
ROA 6-point trend, +61.2% -25.9% -29.8% -40.3% 1.6% -55.7% -66.6% ·
ROE 6-point trend, +52.6% -21.9% -29.8% -28.2% 13.5% -55.4% -46.2% ·
ROIC · · · 0.76% · · ·
Liquidity & Solvency 2
Annual Liquidity & Solvency data for ELVN
Metric Trend 2025202420232022202120202019
Current Ratio 6-point trend, +98.1% 28.7 20.0 10.3 49.0 12.9 14.5 ·
Quick Ratio 6-point trend, +265.7% 27.9 19.7 9.8 48.2 6.7 7.6 ·
Per Share 4
Annual Per Share data for ELVN
Metric Trend 2025202420232022202120202019
Book Value / Share 6-point trend, +60.7% $7.73 $6.33 $5.96 $3.43 $3.27 $4.81 ·
Cash Flow / Share 4-point trend, +8.0% $-1.24 $-1.55 $-1.72 $-1.35 · · ·
Cash / Share 6-point trend, -38.8% $1.66 $2.54 $2.43 $3.36 $1.84 $2.72 ·
EPS (TTM) 5-point trend, +22.8% $-1.83 $-1.89 $-2.01 $-12.05 $-2.37 · ·
Valuation (TTM) 8
Annual Valuation (TTM) data for ELVN
Metric Trend 2025202420232022202120202019
Net Income TTM 6-point trend, -150.7% $-104M $-89M $-72M $-38M $-51M $-41M ·
Market Cap 6-point trend, -40.9% $915M $1.10B $571M $430M $237M $1.55B ·
P/E 5-point trend, -121.6% -8.4 -11.9 -6.9 -1.4 -3.8 · ·
P/B 6-point trend, -89.1% 2.0 3.6 2.3 4.8 2.8 18.3 ·
P / Tangible Book 4-point trend, -89.1% 2.0 3.6 2.3 · · 18.3 ·
P / Cash Flow 6-point trend, +68.5% -13.0 -15.0 -9.3 -12.1 -5.1 -41.4 ·
P / FCF 6-point trend, +68.6% -13.0 -15.0 -9.3 -12.0 -5.1 -41.4 ·
Earnings Yield 5-point trend, +54.9% -11.9% -8.4% -14.5% -73.7% -26.3% · ·

Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years

Income Statement
2025-12-312024-12-312023-12-312022-12-312021-12-31
Net Income $-104M$-89M$-72M$-38M$-51M
Diluted EPS $-1.83$-1.89$-2.01$-12.05$-2.37
Balance Sheet
2025-12-312024-12-312023-12-312022-12-312021-12-31
Current Ratio 28.720.010.349.012.9
Quick Ratio 27.919.79.848.26.7
Cash Flow
2025-12-312024-12-312023-12-312022-12-312021-12-31
Free Cash Flow $-70M$-73M$-61M$-36M$-47M

Latest News Recent headlines mentioning this company

My Metrics Your personal watchlist — selected rows from Full Fundamentals

📊

Pick the metrics that matter to you — click the ➕ next to any row in Full Fundamentals above.

Your selection is saved and follows you across all tickers.

Institutional owners (13F) 221 filers · $3.4B total · As of June 30, 2026

Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.

Institutional activity — Q2 2026 vs prior quarter
New positions Exited positions Increased Decreased Net shares change
62 (-10 vs prior Q) 15 (0 vs prior Q) 77 (+19 vs prior Q) 51 (+18 vs prior Q) +12.8M

Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.

Institution Value Shares % of tracked 13F Type
FMR LLC $449,607,902 8,859,269 13.25% Shares
ORBIMED ADVISORS LLC $343,914,074 6,776,632 10.13% Shares
Polar Capital Holdings Plc $326,354,777 6,430,636 9.62% Shares
Vestal Point Capital, LP $203,000,000 4,000,000 5.98% Shares
Commodore Capital LP $166,206,250 3,275,000 4.90% Shares
VANGUARD CAPITAL MANAGEMENT LLC $130,376,852 2,569,002 3.84% Shares
CITADEL ADVISORS LLC $101,874,840 2,007,386 3.00% Shares
Fairmount Funds Management LLC $94,173,933 1,855,644 2.78% Shares
Siren, L.L.C. $90,051,358 1,774,411 2.65% Shares
Bellevue Group AG $75,617,500 1,490,000 2.23% Shares
First Light Asset Management, LLC $69,058,063 1,360,750 2.04% Shares
GEODE CAPITAL MANAGEMENT, LLC $62,098,160 1,223,306 1.83% Shares
STATE STREET CORP $61,591,012 1,213,616 1.82% Shares
Pictet Asset Management Holding SA $58,960,538 1,161,784 1.74% Shares
ADAGE CAPITAL PARTNERS GP, L.L.C. $54,978,135 1,083,313 1.62% Shares
NOVO HOLDINGS A/S $50,750,000 1,000,000 1.50% Shares
First Turn Management, LLC $48,433,770 954,360 1.43% Shares
BAKER BROS. ADVISORS LP $45,938,443 905,191 1.35% Shares
Candriam S.C.A. $45,918,733 905,674 1.35% Shares
Tri Locum Partners LP $43,985,837 866,716 1.30% Shares
ALLIANCEBERNSTEIN L.P. $35,129,511 896,161 1.04% Shares
DIMENSIONAL FUND ADVISORS LP $31,686,828 624,371 0.93% Shares
Balyasny Asset Management L.P. $30,814,842 607,189 0.91% Shares
AMERICAN CENTURY COMPANIES INC $28,732,976 566,165 0.85% Shares
VANGUARD PORTFOLIO MANAGEMENT LLC $28,560,222 562,763 0.84% Shares
Avidity Partners Management LP $27,912,500 550,000 0.82% Shares
MARSHALL WACE, LLP $26,713,227 526,369 0.79% Shares
Venrock Adviser, LLC $26,711,298 526,331 0.79% Shares
Affinity Asset Advisors, LLC $25,375,000 500,000 0.75% Shares
SILVERARC CAPITAL MANAGEMENT, LLC $24,836,137 489,382 0.73% Shares
Logos Global Management LP $23,598,750 465,000 0.70% Shares
Rock Springs Capital Management LP $23,579,719 464,625 0.69% Shares
CHARLES SCHWAB INVESTMENT MANAGEMENT INC $21,540,330 424,440 0.63% Shares
MILLENNIUM MANAGEMENT LLC $20,876,622 411,362 0.62% Shares
Nicholas Investment Partners, LP $19,870,097 391,529 0.59% Shares
ADAR1 Capital Management, LLC $19,676,689 387,718 0.58% Shares
VANGUARD FIDUCIARY TRUST CO $19,462,118 383,490 0.57% Shares
SAMLYN CAPITAL, LLC $17,678,966 348,354 0.52% Shares
Woodline Partners LP $17,617,457 347,142 0.52% Shares
STEMPOINT CAPITAL LP $17,605,886 346,914 0.52% Shares
Spruce Street Capital LP $16,697,055 329,006 0.49% Shares
Longaeva Partners L.P. $15,862,420 312,560 0.47% Shares
JENNISON ASSOCIATES LLC $15,692,866 309,219 0.46% Shares
Assenagon Asset Management S.A. $15,558,631 306,574 0.46% Shares
D. E. Shaw & Co., Inc. $15,514,427 305,703 0.46% Shares
Seven Fleet Capital Management LP $14,673,652 289,136 0.43% Shares
GOLDMAN SACHS GROUP INC $14,142,655 278,673 0.42% Shares
AMERIPRISE FINANCIAL INC $12,518,808 246,676 0.37% Shares
Deep Track Capital, LP $11,418,750 225,000 0.34% Shares
Blackstone Inc. $10,949,008 215,744 0.32% Shares
Patient Square Capital LP $10,784,375 212,500 0.32% Shares
Soleus Capital Management, L.P. $8,408,108 165,677 0.25% Shares
Squadron Capital Management LLC $8,120,000 160,000 0.24% Shares
Connor, Clark & Lunn Investment Management Ltd. $8,044,992 158,522 0.24% Shares
Integral Health Asset Management, LLC $7,612,500 150,000 0.22% Shares
Cormorant Asset Management, LP $7,612,500 150,000 0.22% Shares
NEUBERGER BERMAN GROUP LLC $7,131,187 140,516 0.21% Shares
HighVista Strategies LLC $6,996,700 137,866 0.21% Shares
Eversept Partners, LP $6,934,023 136,631 0.20% Shares
Ikarian Capital, LLC $6,421,957 126,541 0.19% Shares
SPHERA FUNDS MANAGEMENT LTD. $5,722,824 112,765 0.17% Shares
J. Goldman & Co LP $5,690,547 112,129 0.17% Shares
TD Asset Management Inc $5,569,204 109,738 0.16% Shares
Cinctive Capital Management LP $5,465,166 107,688 0.16% Shares
Exome Asset Management LLC $5,085,302 100,203 0.15% Shares
SUSQUEHANNA INTERNATIONAL GROUP, LLP $4,892,300 96,400 0.14% Call option
Swiss National Bank $4,799,580 94,573 0.14% Shares
VANGUARD GROUP INC $4,679,767 303,881 0.14% Shares
BANK OF AMERICA CORP /DE/ $3,977,531 78,375 0.12% Shares
DV EQUITIES, LLC $3,869,688 76,250 0.11% Shares
MANUFACTURERS LIFE INSURANCE COMPANY, THE $3,819,699 75,265 0.11% Shares
Artia Global Partners LP $3,659,075 72,100 0.11% Shares
ALGERT GLOBAL LLC $3,658,568 72,090 0.11% Shares
CITADEL ADVISORS LLC $3,654,000 72,000 0.11% Put option
Informed Momentum Co LLC $3,574,424 70,432 0.11% Shares
SEVEN GRAND MANAGERS, LLC $3,552,500 70,000 0.10% Shares
GREAT POINT PARTNERS LLC $3,552,500 70,000 0.10% Shares
NEW YORK STATE COMMON RETIREMENT FUND $3,407,913 67,151 0.10% Shares
WELLINGTON MANAGEMENT GROUP LLP $3,307,581 65,174 0.10% Shares
BlackRock, Inc. $3,106,306 61,208 0.09% Shares
RHUMBLINE ADVISERS $2,904,972 57,241 0.09% Shares
Schonfeld Strategic Advisors LLC $2,836,112 55,884 0.08% Shares
Atom Investors LP $2,543,692 50,122 0.07% Shares
Caption Management, LLC $2,537,500 50,000 0.07% Call option
Jones Hill Capital LP $2,529,888 49,850 0.07% Shares
BNP PARIBAS FINANCIAL MARKETS $2,318,514 45,685 0.07% Shares
TUDOR INVESTMENT CORP ET AL $2,035,989 40,118 0.06% Shares
WELLS FARGO & COMPANY/MN $1,983,259 39,079 0.06% Shares
BOOTHBAY FUND MANAGEMENT, LLC $1,980,823 39,031 0.06% Shares
JANE STREET GROUP, LLC $1,908,200 37,600 0.06% Call option
Trexquant Investment LP $1,902,668 37,491 0.06% Shares
Bank of New York Mellon Corp $1,766,658 34,811 0.05% Shares
TimesSquare Capital Management, LLC $1,764,000 45,000 0.05% Shares
VANGUARD ASSET MANAGEMENT, Ltd $1,696,674 33,432 0.05% Shares
Ishara Investments LP $1,664,600 32,800 0.05% Shares
Brevan Howard Capital Management LP $1,660,439 32,718 0.05% Shares
Engineers Gate Manager LP $1,479,464 29,152 0.04% Shares
CITIGROUP INC $1,433,180 28,240 0.04% Shares
Vanguard Global Advisers, LLC $1,361,775 26,833 0.04% Shares
JANE STREET GROUP, LLC $1,344,875 26,500 0.04% Put option

Company insiders 28 insiders · 7 officers · 18 directors

Insider Role Last activity Shares owned Buys 12m Sells 12m Net 12m
Samuel Kintz President and CEO Jan. 25, 2024 M 0 0 0 $0
Benjamin Hohl CHIEF FINANCIAL OFFICER July 17, 2026 M 46,054 0 8 $-580,338
Michael Gray CFO & COO Feb. 22, 2023 S 27,610 0 0 $0
Anish Patel Chief Operating Officer Jan. 22, 2024 S 17,222 0 0 $0
Helen Louise Collins CHIEF MEDICAL OFFICER July 17, 2026 M 25,000 0 8 $-482,386
Joseph P Lyssikatos Chief Scientific Officer Dec. 29, 2023 M 0 0 0 $0
Kenneth Attie SVP, CMO Jan. 28, 2022 A 34,100 0 0 $0
Lori Anne Kunkel Director July 6, 2026 S 41,884 0 3 $-771,524
Rishi Gupta Director May 16, 2024 S 7,663,349 0 0 $0
Richard A. Heyman Director Dec. 22, 2023 S 29,216 0 0 $0
Andrew John Phillips Director Feb. 23, 2023 A 0 0 $0
Rahul D. Ballal Director Feb. 23, 2023 A 87,835 0 0 $0
Jake Bauer Director Feb. 23, 2023 A 87,372 0 0 $0
Andrew J. Schwab Director Feb. 23, 2023 A 960,383 0 0 $0
Laura A Williams Director June 2, 2022 A 0 0 $0
Mark Chin Director June 2, 2022 A 2,344,072 0 0 $0
Edward R. Conner Director June 2, 2022 A 0 0 $0
Barbara Dalton Director June 2, 2022 A 1,557,722 0 0 $0
David P Bonita Director June 2, 2022 A 4,199,068 0 0 $0
David M Mott Director June 2, 2022 A 229,224 0 0 $0
Carl Goldfischer Director June 2, 2022 A 0 0 $0
James G Mcarthur Director March 16, 2020 A 0 0 $0
Mette Kirstine Agger Director March 16, 2020 A 1,432,722 0 0 $0
Alexandria Venture Investments, LLC 10% owner March 16, 2020 C 293,013 0 0 $0
Lundbeckfond Invest A/S 10% owner March 16, 2020 C 1,432,722 0 0 $0
H LUNDBECK A S 10% owner March 16, 2020 C 522,499 0 0 $0
Mika K Derynck Aug. 4, 2026 M 0 0 1 $-9,561,047
Sara M. Nayeem June 29, 2021 A 0 0 $0

Insiders from SEC Form 3/4/5 filings; net = open-market P/S only

Activists & 5%+ owners 7 positions

Investors who filed SEC Schedule 13D — beneficial ownership above 5% with an intent to influence the issuer (activist stakes, board campaigns, M&A). Each row shows the most recent known state of that filer's position.

Filer Filed Stake Status Purpose Filing
ORBIMED ADVISORS LLC, ORBIMED CAPITAL GP VII LLC, ORBIMED GENESIS GP LLC, ORBIMED CAPITAL LLC ×7 filings June 24, 2026 9.50% Amendment SEC
5AM Ventures VI, L.P., 5AM Partners VI, LLC, 5AM Opportunities I, L.P., 5AM Opportunities I (GP), LLC, Kush Parmar, Andrew J. Schwab ×5 filings July 29, 2024 Initial filing SEC
5AM Partners VI, LLC, 5AM Opportunities I, L.P., 5AM Opportunities I (GP), LLC, Kush Parmar, Andrew J. Schwab March 6, 2023 Initial filing Passive investment SEC
May 24, 2022 Initial filing SEC
New Enterprise Associates 14, L.P., NEA Partners 14, L.P., NEA 14 GP, LTD, Forest Baskett, Anthony A. Florence, Jr., Patrick J. Kerins, Scott D. Sandell, Peter W. Sonsini ×3 filings April 25, 2022 Initial filing Passive investment SEC
Arix Bioscience Plc, Arix Bioscience Holdings Limited, Mark Chin ×3 filings July 20, 2021 Initial filing SEC
Arix Bioscience Plc (2), Arix Bioscience Holdings Limited (2), Mark Chin (1) (2) March 24, 2020 Initial filing SEC

Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.

ETF ownership Held by 48 ETFs

Weight reflects direct equity holdings (N-PORT) only; leveraged or derivative-based funds may hold additional swap exposure not shown.

Fund Weight Units As of Source
BBC · ETFis Series Trust I 1.81% 16,370 NS April 30, 2026 N-PORT
PTH · Invesco Exchange-Traded Fund Trust 1.80% 73,604 SH Aug. 8, 2026 Daily
PILL · Direxion Shares ETF Trust 1.80% 5,620 NS April 30, 2026 N-PORT
CANC · Tema ETF Trust 1.31% 58,197 NS May 31, 2026 N-PORT
FMED · Fidelity Covington Trust 1.03% 10,703 NS May 31, 2026 N-PORT
IHE · iShares Trust 0.72% 194,624 SH Aug. 8, 2026 Daily
DWAS · Invesco Exchange-Traded Fund Trust … 0.51% 38,057 SH Aug. 8, 2026 Daily
IBB · iShares Trust 0.26% 407,872 SH Aug. 8, 2026 Daily
IBBQ · Invesco Exchange-Traded Fund Trust … 0.25% 3,315 SH Aug. 8, 2026 Daily
ESSC · Strategy Shares 0.23% 1,424 NS April 30, 2026 N-PORT
FFSM · FIDELITY COVINGTON TRUST 0.16% 51,358 NS April 30, 2026 N-PORT
IWO · iShares Trust 0.16% 388,661 SH Aug. 8, 2026 Daily
VTWG · VANGUARD SCOTTSDALE FUNDS 0.13% 45,928 SH Aug. 8, 2026 Daily
VFMO · VANGUARD WELLINGTON FUND 0.12% 47,349 SH Aug. 8, 2026 Daily
BIB · ProShares Trust 0.12% 2,196 NS May 31, 2026 N-PORT
NUSC · Nushares ETF Trust 0.11% 34,350 NS April 30, 2026 N-PORT
AVSC · AMERICAN CENTURY ETF TRUST 0.09% 61,669 NS May 31, 2026 N-PORT
IWM · iShares Trust 0.08% 1,094,617 SH Aug. 8, 2026 Daily
ISCG · iShares Trust 0.07% 12,024 SH Aug. 8, 2026 Daily
VTWO · VANGUARD SCOTTSDALE FUNDS 0.07% 246,533 SH Aug. 8, 2026 Daily
ESML · iShares Trust 0.07% 33,580 SH Aug. 8, 2026 Daily
ISCB · iShares Trust 0.05% 2,494 SH Aug. 8, 2026 Daily
DFAS · Dimensional ETF Trust 0.05% 175,955 NS April 30, 2026 N-PORT
VHT · VANGUARD WORLD FUND 0.04% 141,971 SH Aug. 8, 2026 Daily
ITWO · ProShares Trust 0.04% 1,852 NS May 31, 2026 N-PORT
SCHA · SCHWAB STRATEGIC TRUST 0.04% 214,005 NS May 31, 2026 N-PORT
ISCV · iShares Trust 0.03% 3,976 SH Aug. 8, 2026 Daily
VXF · VANGUARD INDEX FUNDS 0.03% 624,513 SH Aug. 8, 2026 Daily
WSML · iShares Trust 0.03% 2,892 SH Aug. 8, 2026 Daily
UWM · ProShares Trust 0.02% 1,449 NS May 31, 2026 N-PORT
FHLC · FIDELITY COVINGTON TRUST 0.02% 14,804 NS April 30, 2026 N-PORT
PRFZ · Invesco Exchange-Traded Fund Trust 0.02% 8,632 SH Aug. 8, 2026 Daily
URTY · ProShares Trust 0.02% 1,465 NS May 31, 2026 N-PORT
MSSM · MORGAN STANLEY PATHWAY FUNDS 0.01% 1,649 NS May 31, 2026 N-PORT
ONEQ · Fidelity Commonwealth Trust 0.01% 22,815 NS May 31, 2026 N-PORT
HDG · ProShares Trust 0.01% 37 NS May 31, 2026 N-PORT
DCOR · Dimensional ETF Trust 0.01% 4,666 NS April 30, 2026 N-PORT
DXUV · Dimensional ETF Trust 0.01% 569 NS April 30, 2026 N-PORT
ITOT · iShares Trust 0.00% 66,943 SH Aug. 8, 2026 Daily
IWV · iShares Trust 0.00% 12,036 SH Aug. 8, 2026 Daily
DFUS · Dimensional ETF Trust 0.00% 14,379 NS April 30, 2026 N-PORT
DFAU · Dimensional ETF Trust 0.00% 7,755 NS April 30, 2026 N-PORT
SCHB · SCHWAB STRATEGIC TRUST 0.00% 30,821 NS May 31, 2026 N-PORT
DFAC · Dimensional ETF Trust 0.00% 28,939 NS April 30, 2026 N-PORT
TILT · FlexShares Trust 0.00% 154 NS April 30, 2026 N-PORT
AVUS · AMERICAN CENTURY ETF TRUST 0.00% 691 NS May 31, 2026 N-PORT
VTI · VANGUARD INDEX FUNDS 0.00% 1,883,832 SH Aug. 8, 2026 Daily
VTHR · VANGUARD SCOTTSDALE FUNDS 0.00% 3,533 SH Aug. 8, 2026 Daily